GEORGE DOWELL: Open Payments
NPI 1750491130 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 16 payments from 7 companies in 2025. Trend: 2023 $552 · 2024 $408 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $202 |
| Lundbeck LLC | 4 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Almatica Pharma LLC | 1 | $14 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
| Corium, LLC | 2 | $11 |
Products named: VRAYLAR, REXULTI, CAPLYTA, LOREEV XR, INGREZZA, Azstarys.
Industry payments across MO — which companies pay providers there.
